You just read:

Elusys Therapeutics Receives FDA Approval For ANTHIM® (obiltoxaximab) Injection For The Treatment And Prophylaxis Of Inhalational Anthrax

News provided by

Elusys Therapeutics, Inc.

Mar 21, 2016, 10:04 ET